« Previous
Next »
JAMDA
Volume 8, Issue 9
, Pages 604-606
, November 2007
Prevalence of Adequate and of Optimal Control of Serum Low-Density Lipoprotein Cholesterol in an Academic Nursing Home
References
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
- . Updated National Cholesterol Education Program III guidelines. J Am Med Dir Assoc. 2005;6:160–161
- . The application of evidence-based principles of care in older persons (issue 2): Management of lipid disorders. J Am Med Dir Assoc. 2006;7:173–179
- . Managing hyperlipidaemia in the elderly (Special considerations for a population at high risk). Drugs Aging. 2006;23:181–189
- . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet. 2002;360:7–22
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet. 2002;360:1623–1630
- Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis (A randomized controlled trial). JAMA. 2004;291:1071–1080
- Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–1504
- Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425–1435
- Effect of very high-intensity statin therapy on regression of coronary atherosclerosis (The ASTEROID trial). JAMA. 2006;295:1556–1575
- . Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drug. Am J Cardiol. 2002;89:67–69
- . Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drug. J Gerontol A Biol Sci Med Sci. 2002;57A:M333–M335
- . Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drug. Am J Cardiol. 2002;90:147–149
- . Reduction of new coronary events and of new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins. J Gerontol A Biol Sci Med Sci. 2002;57A:M747–M750
- . Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drug. Am J Cardiol. 2002;90:789–791
- . Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. Am J Cardiol. 2003;92:711–712
- . Utilization of lipid-lowering drugs in elderly persons with increased serum low-density lipoprotein cholesterol associated with coronary artery disease, symptomatic peripheral arterial disease, prior stroke, or diabetes mellitus before and after an educational program on dyslipidemia treatment. J Gerontol A Biol Sci Med Sci. 2003;58A:M432–M435
None of the authors have any conflicts of interest pertaining to this study.
PII: S1525-8610(07)00352-0
doi: 10.1016/j.jamda.2007.08.001
© 2007 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
JAMDA
Volume 8, Issue 9
, Pages 604-606
, November 2007
